Floatz logo

OXYCODONE HYDROCHLORIDE, HYDROCODONE-

Dementia, Vascular

VA Office of Research and DevelopmentSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Dementia, Vascular cohort.

Asset / SponsorPhaseRating
PITTSBURGH COMPOUND B UNLABELLED
National Taiwan University Hospital
Phase 4BB
Risperdal
Janssen-Cilag Pty Ltd
Phase 3BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Peking University First Hospital
Phase 4BB
Acetylsalicylic Acid
Peking University First Hospital
Phase 4BB
Rivastigmine
Novartis
Phase 3BB

View all 42 →

Same molecule, other indications

OXYCODONE HYDROCHLORIDE, HYDROCODONE- is also rated in:

chronic pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
PainDormant
BB
Indicative ·
67 / 100
View asset →
Colon DiverticulosisDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →